United Therapeutics Corporation (UTHR) Insider Trading
- $999,400.80
- $687,102,758.43
- April 30, 2024
- Martine A Rothblatt
Trader Name | Date | Title | Amount | Price | Type | Total Value |
---|---|---|---|---|---|---|
April 3, 2018 | CEO | 22,059 | $114.44 | Sell | $2,524,431.96 | |
March 29, 2018 | CEO | 43,024 | $111.14 | Sell | $4,781,687.36 | |
March 22, 2018 | CEO | 1,100 | $110.01 | Sell | $121,011.00 | |
March 20, 2018 | CEO | 301 | $110.48 | Sell | $33,254.48 | |
March 16, 2018 | CEO | 43,025 | $111.11 | Sell | $4,780,507.75 | |
March 14, 2018 | CEO | 21,512 | $112.55 | Sell | $2,421,175.60 | |
Dec. 8, 2017 | CEO | 1 | $136.16 | Sell | $136.16 | |
Dec. 7, 2017 | Director | 580 | $134.72 | Sell | $78,137.60 | |
Nov. 30, 2017 | CEO | 1,241 | $128.95 | Sell | $160,026.95 | |
Nov. 24, 2017 | CEO | 1,253 | $124.07 | Sell | $155,459.71 | |
Nov. 16, 2017 | CEO | 7,061 | $121.12 | Sell | $855,228.32 | |
Nov. 9, 2017 | CEO | 1,260 | $121.46 | Sell | $153,039.60 | |
Nov. 6, 2017 | Director | 580 | $122.00 | Sell | $70,760.00 | |
Nov. 2, 2017 | CEO | 1,269 | $118.04 | Sell | $149,792.76 | |
Oct. 26, 2017 | CEO | 1,263 | $120.38 | Sell | $152,039.94 | |
Oct. 19, 2017 | CEO | 1,265 | $119.38 | Sell | $151,015.70 | |
Oct. 12, 2017 | CEO | 1,263 | $120.20 | Sell | $151,812.60 | |
Oct. 5, 2017 | CEO | 1,256 | $122.98 | Sell | $154,462.88 | |
Oct. 5, 2017 | Director | 580 | $122.00 | Sell | $70,760.00 | |
Sept. 28, 2017 | CEO | 1,265 | $119.70 | Sell | $151,420.50 | |
Sept. 21, 2017 | CEO | 1,274 | $116.07 | Sell | $147,873.18 | |
Sept. 14, 2017 | CEO | 1,258 | $122.08 | Sell | $153,576.64 | |
Sept. 7, 2017 | Director | 580 | $134.48 | Sell | $77,998.40 | |
Sept. 7, 2017 | CEO | 1,232 | $133.32 | Sell | $164,250.24 | |
Aug. 31, 2017 | CEO | 1,235 | $130.49 | Sell | $161,155.15 | |
Aug. 24, 2017 | CEO | 1,238 | $130.65 | Sell | $161,744.70 | |
Aug. 17, 2017 | CEO | 1,235 | $131.95 | Sell | $162,958.25 | |
Aug. 10, 2017 | CEO | 2,176 | $127.11 | Sell | $276,591.36 | |
Aug. 3, 2017 | CEO | 1,248 | $126.41 | Sell | $157,759.68 | |
July 27, 2017 | CEO | 1,247 | $126.40 | Sell | $157,620.80 | |
July 20, 2017 | CEO | 1,236 | $131.62 | Sell | $162,682.32 | |
July 13, 2017 | CEO | 1,238 | $130.44 | Sell | $161,484.72 | |
July 6, 2017 | Director | 590 | $132.61 | Sell | $78,239.90 | |
July 6, 2017 | CEO | 1,234 | $132.29 | Sell | $163,245.86 | |
July 5, 2017 | Director | 3,490 | $131.12 | Sell | $457,608.80 | |
June 29, 2017 | CEO | 1,237 | $130.92 | Sell | $161,948.04 | |
June 23, 2017 | Director | 3,490 | $131.71 | Sell | $459,667.90 | |
June 22, 2017 | CEO | 1,234 | $132.32 | Sell | $163,282.88 | |
June 15, 2017 | CEO | 1,238 | $130.20 | Sell | $161,187.60 | |
June 8, 2017 | CEO | 1,240 | $129.60 | Sell | $160,704.00 | |
June 1, 2017 | CEO | 1,251 | $125.02 | Sell | $156,400.02 | |
May 25, 2017 | CEO | 1,265 | $119.40 | Sell | $151,041.00 | |
May 18, 2017 | CEO | 1,261 | $120.72 | Sell | $152,227.92 | |
May 11, 2017 | CEO | 1,259 | $122.00 | Sell | $153,598.00 | |
May 4, 2017 | CEO | 1,258 | $122.24 | Sell | $153,777.92 | |
April 27, 2017 | CEO | 1,262 | $120.78 | Sell | $152,424.36 | |
April 20, 2017 | CEO | 1,260 | $121.14 | Sell | $152,636.40 | |
April 13, 2017 | CEO | 1,258 | $122.12 | Sell | $153,626.96 | |
April 6, 2017 | CEO | 1,257 | $122.39 | Sell | $153,844.23 | |
March 30, 2017 | CEO | 1,230 | $134.56 | Sell | $165,508.80 |
Insiders are both buying and selling United Therapeutics Corporation stock.
The insider traders at United Therapeutics Corporation are: Martine A Rothblatt, Paul A Mahon, Roger Jeffs, Martine A. Rothblatt, Martine Rothblatt, Christopher Causey, John Maxim Ferrari, Raymond Dwek, Christopher Patusky, Paul Mahon, David Zaccardelli, Richard Giltner, Louis W Sullivan, Tommy G Thompson, Nilda Mesa, Judy D Olian, Paul A. Mahon, Ray Kurzweil, Tommy G. Thompson, MAHON PAUL A, Judy D. Olian, DWEK RAYMOND, R Paul Gray, and Louis Sullivan
The most active insider trader at United Therapeutics Corporation is Martine A Rothblatt with 353 trades.
Martine A Rothblatt has sold the most United Therapeutics Corporation stock with a total value of $338,583,958.82.
Martine A Rothblatt has bought the most United Therapeutics Corporation stock with a total value of $1,217,751.60.
The most recent insider trade for United Therapeutics Corporation was on April 30, 2024.
The single biggest insider buy for United Therapeutics Corporation was from Martine A Rothblatt with a total value of $466,650.00 on Dec. 21, 2012.
The single biggest insider sell for United Therapeutics Corporation was from Roger Jeffs with a total value of $6,551,000.00 on Sept. 23, 2014.